{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:32:31Z","timestamp":1776281551560,"version":"3.50.1"},"reference-count":66,"publisher":"Siapec Servizi Srl","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-161","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T13:39:00Z","timestamp":1611754740000},"page":"227-247","source":"Crossref","is-referenced-by-count":12,"title":["Gastrointestinal lymphoproliferative lesions: a practical diagnostic approach"],"prefix":"10.32074","volume":"112","author":[{"given":"Marco","family":"Pizzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Sabattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Parente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Doglioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Lazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21774","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"10.32074\/1591-951X-161_ref1","doi-asserted-by":"crossref","unstructured":"Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol 2014;14:667-85. https:\/\/doi.org\/10.1038\/nri3738","DOI":"10.1038\/nri3738"},{"key":"10.32074\/1591-951X-161_ref2","doi-asserted-by":"crossref","unstructured":"Brandtzaeg P, Kiyono H, Pabst R, et al. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 2008;1:31-7. https:\/\/doi.org\/10.1038\/mi.2007.9","DOI":"10.1038\/mi.2007.9"},{"key":"10.32074\/1591-951X-161_ref3","unstructured":"Swerdlow SH, World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer 2017."},{"key":"10.32074\/1591-951X-161_ref4","doi-asserted-by":"crossref","unstructured":"Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol 2011;17:697-707. https:\/\/doi.org\/10.3748\/wjg.v17.i6.697","DOI":"10.3748\/wjg.v17.i6.697"},{"key":"10.32074\/1591-951X-161_ref5","doi-asserted-by":"crossref","unstructured":"Nakamura S, Ponzoni M. Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches. Pathology 2020:52:15-29. https:\/\/doi.org\/10.1016\/j.pathol.2019.08.012","DOI":"10.1016\/j.pathol.2019.08.012"},{"key":"10.32074\/1591-951X-161_ref6","doi-asserted-by":"crossref","unstructured":"Duffles Amarante G, Collins G, Rocha V. What do we know about duodenal-type follicular lymphoma? From pathological definition to treatment options. Br J Haematol 2020:188:831-7. https:\/\/doi.org\/10.1111\/bjh.16348","DOI":"10.1111\/bjh.16348"},{"key":"10.32074\/1591-951X-161_ref7","doi-asserted-by":"crossref","unstructured":"van Vliet C, Spagnolo DV. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update. Pathology 2020:52:128-41. https:\/\/doi.org\/10.1016\/j.pathol.2019.10.001","DOI":"10.1016\/j.pathol.2019.10.001"},{"key":"10.32074\/1591-951X-161_ref8","doi-asserted-by":"crossref","unstructured":"Ott G. Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings. Br J Haematol 2017:178:871-87. https:\/\/doi.org\/10.1111\/bjh.14744","DOI":"10.1111\/bjh.14744"},{"key":"10.32074\/1591-951X-161_ref9","doi-asserted-by":"crossref","unstructured":"Jain P, Wang M. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol 2019:94:710-25. https:\/\/doi.org\/10.1002\/ajh.25487.","DOI":"10.1002\/ajh.25487"},{"key":"10.32074\/1591-951X-161_ref10","doi-asserted-by":"crossref","unstructured":"Montes-Moreno S, King RL, Oschlies I, et al. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas. Virchows Arch 2020:476:667-81. https:\/\/doi.org\/10.1007\/s00428-019-02704-8","DOI":"10.1007\/s00428-019-02704-8"},{"key":"10.32074\/1591-951X-161_ref11","doi-asserted-by":"crossref","unstructured":"Lo WY, Li JY, Chan YK, et al. Instability of clonality in gastric lymphoid infiltrates: a study with emphasis on serial biopsies. Am J Surg Pathol 2005:29:1582-92. https:\/\/doi.org\/10.1097\/01.pas.0000188031.40836.00","DOI":"10.1097\/01.pas.0000188031.40836.00"},{"key":"10.32074\/1591-951X-161_ref12","doi-asserted-by":"crossref","unstructured":"Theriault C, Galoin S, Valmary S, et al. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol 2000:13:1269-79. https:\/\/doi.org\/10.1038\/modpathol.3880232","DOI":"10.1038\/modpathol.3880232"},{"key":"10.32074\/1591-951X-161_ref13","doi-asserted-by":"crossref","unstructured":"Hussein MR. Atypical lymphoid proliferations: the pathologist\u2019s viewpoint. Expert Rev Hematol 2013:6:139-53. https:\/\/doi.org\/10.1586\/ehm.13.4","DOI":"10.1586\/ehm.13.4"},{"key":"10.32074\/1591-951X-161_ref14","doi-asserted-by":"crossref","unstructured":"Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 1961:49:80-9. https:\/\/doi.org\/10.1002\/bjs.18004921319","DOI":"10.1002\/bjs.18004921319"},{"key":"10.32074\/1591-951X-161_ref15","doi-asserted-by":"crossref","unstructured":"Loehr WJ, Mujahed Z, Zahn FD, et al. Primary lymphoma of the gastrointestinal tract: a review of 100 cases. Ann Surg 1969:170:232-8","DOI":"10.1097\/00000658-196908000-00011"},{"key":"10.32074\/1591-951X-161_ref16","doi-asserted-by":"crossref","unstructured":"Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972:29:252-60. https:\/\/doi.org\/10.1097\/00000658-196908000-00011","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#"},{"key":"10.32074\/1591-951X-161_ref17","doi-asserted-by":"crossref","unstructured":"Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin\u2019s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01\/92. J Clin Oncol 2001:19:3861-73. https:\/\/doi.org\/10.1200\/JCO.2001.19.18.3861","DOI":"10.1200\/JCO.2001.19.18.3861"},{"key":"10.32074\/1591-951X-161_ref18","doi-asserted-by":"crossref","unstructured":"Salem P, el-Hashimi L, Anaissie E, et al. Primary small intestinal lymphoma in adults. A comparative study of IPSID versus non-IPSID in the Middle East. Cancer 1987:59:1670-6. doi:10.1002\/1097-0142(19870501)59:9<1670::aid-cncr2820590925>3.0.co;2-d","DOI":"10.1002\/1097-0142(19870501)59:9<1670::AID-CNCR2820590925>3.0.CO;2-D"},{"key":"10.32074\/1591-951X-161_ref19","doi-asserted-by":"crossref","unstructured":"Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood 2005:105:2274-80. https:\/\/doi.org\/10.1182\/blood-2004-07-2755","DOI":"10.1182\/blood-2004-07-2755"},{"key":"10.32074\/1591-951X-161_ref20","doi-asserted-by":"crossref","unstructured":"Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993:342(8871):575-7. https:\/\/doi.org\/10.1016\/0140-6736(93)91409-f","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"10.32074\/1591-951X-161_ref21","doi-asserted-by":"crossref","unstructured":"Copie-Bergman C, Gaulard P, Lavergne-Slove A, et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 2003:52:1656. https:\/\/doi.org\/10.1136\/gut.52.11.1656","DOI":"10.1136\/gut.52.11.1656"},{"key":"10.32074\/1591-951X-161_ref22","doi-asserted-by":"crossref","unstructured":"Attygalle AD, Liu H, Shirali S, et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood 2004:104:3343-8. https:\/\/doi.org\/10.1182\/blood-2004-01-0385","DOI":"10.1182\/blood-2004-01-0385"},{"key":"10.32074\/1591-951X-161_ref23","doi-asserted-by":"crossref","unstructured":"Marks E, Shi Y. Duodenal-type follicular lymphoma: a clinicopathologic review. Arch Pathol Lab Med 2018:142:542-7. https:\/\/doi.org\/10.5858\/arpa.2016-0519-RS","DOI":"10.5858\/arpa.2016-0519-RS"},{"key":"10.32074\/1591-951X-161_ref24","doi-asserted-by":"crossref","unstructured":"Misdraji J, Harris NL, Hasserjian RP, et al. Primary follicular lymphoma of the gastrointestinal tract. Am J Surg Pathol 2011:35:1255-63. https:\/\/doi.org\/10.1097\/PAS.0b013e318224e661","DOI":"10.1097\/PAS.0b013e318224e661"},{"key":"10.32074\/1591-951X-161_ref25","doi-asserted-by":"crossref","unstructured":"Miao Y, Lin P, Saksena A, et al. CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 patients. Am J Surg Pathol 2019:43:1052-60. https:\/\/doi.org\/10.1097\/PAS.0000000000001278","DOI":"10.1097\/PAS.0000000000001278"},{"key":"10.32074\/1591-951X-161_ref26","doi-asserted-by":"crossref","unstructured":"Pizzi M, Agostinelli C, Righi S, et al. Aberrant expression of CD10 and BCL6 in mantle cell lymphoma. Histopathology 2017:71:769-77. https:\/\/doi.org\/10.1111\/his.13286","DOI":"10.1111\/his.13286"},{"key":"10.32074\/1591-951X-161_ref27","doi-asserted-by":"crossref","unstructured":"Ye H, Desai A, Zeng D, et al. Smoldering mantle cell lymphoma. J Exp Clin Cancer Res 2017:36:185. https:\/\/doi.org\/10.1186\/s13046-017-0652-8","DOI":"10.1186\/s13046-017-0652-8"},{"key":"10.32074\/1591-951X-161_ref28","doi-asserted-by":"crossref","unstructured":"Espinet B, Ferrer A, Bellosillo B, et al. Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry. Clin Cancer Res 2014:20:1007-19. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1077","DOI":"10.1158\/1078-0432.CCR-13-1077"},{"key":"10.32074\/1591-951X-161_ref29","doi-asserted-by":"crossref","unstructured":"Zhang XM, Aguilera N. New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma. Arch Pathol Lab Med 2014:138:1666-72. https:\/\/doi.org\/10.5858\/arpa.2014-0058-RA","DOI":"10.5858\/arpa.2014-0058-RA"},{"key":"10.32074\/1591-951X-161_ref30","doi-asserted-by":"crossref","unstructured":"Piccaluga PP, De Falco G, Kustagi M, et al. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood 2011:117:3596-3608. https:\/\/doi.org\/10.1182\/blood-2010-08-301556","DOI":"10.1182\/blood-2010-08-301556"},{"key":"10.32074\/1591-951X-161_ref31","doi-asserted-by":"crossref","unstructured":"Ambrosio MR, Piccaluga PP, Ponzoni M, et al. The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin. PLoS One 2012:7:e44315. https:\/\/doi.org\/10.1371\/journal.pone.0044315","DOI":"10.1371\/journal.pone.0044315"},{"key":"10.32074\/1591-951X-161_ref32","doi-asserted-by":"crossref","unstructured":"Mundo L, Ambrosio MR, Raimondi F, et al. Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases. Blood Cancer J 2019:9:91. https:\/\/doi.org\/10.1038\/s41408-019-0252-2","DOI":"10.1038\/s41408-019-0252-2"},{"key":"10.32074\/1591-951X-161_ref33","doi-asserted-by":"crossref","unstructured":"Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med 2006:354:2419-30. https:\/\/doi.org\/10.1056\/NEJMoa055351","DOI":"10.1056\/NEJMoa055351"},{"key":"10.32074\/1591-951X-161_ref34","doi-asserted-by":"crossref","unstructured":"Leucci E, Cocco M, Onnis A, et al. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 2008:216:440-50. https:\/\/doi.org\/10.1002\/path.2410","DOI":"10.1002\/path.2410"},{"key":"10.32074\/1591-951X-161_ref35","doi-asserted-by":"crossref","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016:127:2375-90. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","DOI":"10.1182\/blood-2016-01-643569"},{"key":"10.32074\/1591-951X-161_ref36","doi-asserted-by":"crossref","unstructured":"Naresh KN, Ibrahim HA, Lazzi S, et al. Diagnosis of Burkitt lymphoma using an algorithmic approach--applicable in both resource-poor and resource-rich countries. Br J Haematol 2011:154:770-6. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08771.x","DOI":"10.1111\/j.1365-2141.2011.08771.x"},{"key":"10.32074\/1591-951X-161_ref37","doi-asserted-by":"crossref","unstructured":"Wagener R, Seufert J, Raimondi F, et al. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Blood 2019:133:962-6. https:\/\/doi.org\/10.1182\/blood-2018-07-864025","DOI":"10.1182\/blood-2018-07-864025"},{"key":"10.32074\/1591-951X-161_ref38","doi-asserted-by":"crossref","unstructured":"Xie Y, Pittaluga S, Jaffe ES. The histological classification of diffuse large B-cell lymphomas. Semin Hematol 2015:52:57-66. https:\/\/doi.org\/10.1053\/j.seminhematol.2015.01.006","DOI":"10.1053\/j.seminhematol.2015.01.006"},{"key":"10.32074\/1591-951X-161_ref39","doi-asserted-by":"crossref","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000:403(6769):503-11. https:\/\/doi.org\/10.1038\/35000501","DOI":"10.1038\/35000501"},{"key":"10.32074\/1591-951X-161_ref40","doi-asserted-by":"crossref","unstructured":"Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004:103:275-82. https:\/\/doi.org\/10.1182\/blood-2003-05-1545","DOI":"10.1182\/blood-2003-05-1545"},{"key":"10.32074\/1591-951X-161_ref41","doi-asserted-by":"crossref","unstructured":"Visco C, Li Y, Xu-Monette ZY, et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 2012:26:2103-13. https:\/\/doi.org\/10.1038\/leu.2012.83","DOI":"10.1038\/leu.2012.83"},{"key":"10.32074\/1591-951X-161_ref42","doi-asserted-by":"crossref","unstructured":"Choi WW, Weisenburger DD, Greiner TC, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 2009:15:5494-5502. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0113","DOI":"10.1158\/1078-0432.CCR-09-0113"},{"key":"10.32074\/1591-951X-161_ref43","doi-asserted-by":"crossref","unstructured":"Li L, Li Y, Que X, et al. Prognostic significances of overexpression MYC and\/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: a systematic review and meta-analysis. Sci Rep 2018:8:6267. https:\/\/doi.org\/10.1038\/s41598-018-24631-5","DOI":"10.1038\/s41598-018-24631-5"},{"key":"10.32074\/1591-951X-161_ref44","doi-asserted-by":"crossref","unstructured":"Ziepert M, Lazzi S, Santi R, et al. A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients. Haematologica 2020. https:\/\/doi.org\/10.3324\/haematol.2019.235556. Online ahead of print","DOI":"10.3324\/haematol.2019.235556"},{"key":"10.32074\/1591-951X-161_ref45","doi-asserted-by":"crossref","unstructured":"Di Napoli A, Remotti D, Agostinelli C, et al. A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double\/triple hit era: selecting cases, matching clinical benefit: a position paper from the Italian Group of Haematopathology (G.I.E.). Virchows Arch 2019:475:513-18. https:\/\/doi.org\/10.1007\/s00428-019-02637-2","DOI":"10.1007\/s00428-019-02637-2"},{"key":"10.32074\/1591-951X-161_ref46","doi-asserted-by":"crossref","unstructured":"Rimsza L, Pittaluga S, Dirnhofer S, et al. The clinicopathologic spectrum of mature aggressive B cell lymphomas. Virchows Arch 2017:471:453-66. https:\/\/doi.org\/10.1007\/s00428-017-2199-7","DOI":"10.1007\/s00428-017-2199-7"},{"key":"10.32074\/1591-951X-161_ref47","doi-asserted-by":"crossref","unstructured":"Li S, Desai P, Lin P, et al. MYC\/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis. Histopathology 2016:68:1090-8. https:\/\/doi.org\/10.1111\/his.12884","DOI":"10.1111\/his.12884"},{"key":"10.32074\/1591-951X-161_ref48","doi-asserted-by":"crossref","unstructured":"Salaverria I, Philipp C, Oschlies I, et al. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood 2011:118:139-47. https:\/\/doi.org\/10.1182\/blood-2011-01-330795","DOI":"10.1182\/blood-2011-01-330795"},{"key":"10.32074\/1591-951X-161_ref49","doi-asserted-by":"crossref","unstructured":"Luria L, Nguyen J, Zhou J, et al. Manifestations of gastrointestinal plasmablastic lymphoma: a case series with literature review. World J Gastroenterol 2014:20:11894-11903. https:\/\/doi.org\/10.3748\/wjg.v20.i33.11894","DOI":"10.3748\/wjg.v20.i33.11894"},{"key":"10.32074\/1591-951X-161_ref50","doi-asserted-by":"crossref","unstructured":"Lorsbach RB, Hsi ED, Dogan A, et al. Plasma cell myeloma and related neoplasms. Am J Clin Pathol 2011:136:168-82. https:\/\/doi.org\/10.1309\/AJCPENJ68FFBRIYB","DOI":"10.1309\/AJCPENJ68FFBRIYB"},{"key":"10.32074\/1591-951X-161_ref51","doi-asserted-by":"crossref","unstructured":"Gao Y, Kristinsson SY, Goldin LR, et al. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology 2009:136:91-8. https:\/\/doi.org\/10.1053\/j.gastro.2008.09.031.","DOI":"10.1053\/j.gastro.2008.09.031"},{"key":"10.32074\/1591-951X-161_ref52","doi-asserted-by":"crossref","unstructured":"Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001:358(9279):356-61. https:\/\/doi.org\/10.1016\/s0140-6736(01)05554-4","DOI":"10.1016\/S0140-6736(01)05554-4"},{"key":"10.32074\/1591-951X-161_ref53","doi-asserted-by":"crossref","unstructured":"Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 2011:118:148-55. https:\/\/doi.org\/10.1182\/blood-2011-02-335216","DOI":"10.1182\/blood-2011-02-335216"},{"key":"10.32074\/1591-951X-161_ref54","doi-asserted-by":"crossref","unstructured":"van Gils T, Nijeboer P, van Wanrooij RL, et al. Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol 2015:12:572-579. https:\/\/doi.org\/10.1038\/nrgastro.2015.155","DOI":"10.1038\/nrgastro.2015.155"},{"key":"10.32074\/1591-951X-161_ref55","doi-asserted-by":"crossref","unstructured":"Chander U, Leeman-Neill RJ, Bhagat G. Pathogenesis of Enteropathy-Associated T Cell Lymphoma. Curr Hematol Malig Rep 2018:13:308-17. https:\/\/doi.org\/10.1007\/s11899-018-0459-5","DOI":"10.1007\/s11899-018-0459-5"},{"key":"10.32074\/1591-951X-161_ref56","doi-asserted-by":"crossref","unstructured":"Inghirami G, Pileri SA, European TCLSG. Anaplastic large-cell lymphoma. Semin Diagn Pathol 2011:28:190-201. https:\/\/doi.org\/10.1053\/j.semdp.2011.03.002","DOI":"10.1053\/j.semdp.2011.03.002"},{"key":"10.32074\/1591-951X-161_ref57","doi-asserted-by":"crossref","unstructured":"Tan SY, Ooi AS, Ang MK, et al. Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma. Leukemia 2011:25:555-7. https:\/\/doi.org\/10.1038\/leu.2010.295","DOI":"10.1038\/leu.2010.295"},{"key":"10.32074\/1591-951X-161_ref58","doi-asserted-by":"crossref","unstructured":"Tan SY, Chuang SS, Tang T, et al. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype. Leukemia 2013:27:1688-96. https:\/\/doi.org\/10.1038\/leu.2013.41","DOI":"10.1038\/leu.2013.41"},{"key":"10.32074\/1591-951X-161_ref59","doi-asserted-by":"crossref","unstructured":"Yu BH, Shui RH, Sheng WQ, et al. Primary intestinal extranodal natural killer\/t-cell lymphoma, nasal type: a comprehensive clinicopathological analysis of 55 cases. PLoS One 2016:11:e0161831. https:\/\/doi.org\/10.1371\/journal.pone.0161831","DOI":"10.1371\/journal.pone.0161831"},{"key":"10.32074\/1591-951X-161_ref60","doi-asserted-by":"crossref","unstructured":"Pongpruttipan T, Sukpanichnant S, Assanasen T, et al. Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta\/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol 2012:36:481-99. https:\/\/doi.org\/10.1097\/PAS.0b013e31824433d8","DOI":"10.1097\/PAS.0b013e31824433d8"},{"key":"10.32074\/1591-951X-161_ref61","doi-asserted-by":"crossref","unstructured":"Attygalle AD, Cabecadas J, Gaulard P, et al. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology 2014:64:171-99. https:\/\/doi.org\/10.1111\/his.12251","DOI":"10.1111\/his.12251"},{"key":"10.32074\/1591-951X-161_ref62","doi-asserted-by":"crossref","unstructured":"Perry AM, Warnke RA, Hu Q, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood 2013:122:3599-3606. https:\/\/doi.org\/10.1182\/blood-2013-07-512830","DOI":"10.1182\/blood-2013-07-512830"},{"key":"10.32074\/1591-951X-161_ref63","doi-asserted-by":"crossref","unstructured":"Soderquist CR, Patel N, Murty VV, et al. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract. Haematologica 2019. https:\/\/doi.org\/10.3324\/haematol.2019.230961. Online ahead of print.","DOI":"10.3324\/haematol.2019.230961"},{"key":"10.32074\/1591-951X-161_ref64","doi-asserted-by":"crossref","unstructured":"Takeuchi K, Yokoyama M, Ishizawa S, et al. Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood 2010:116:5631-7. https:\/\/doi.org\/10.1182\/blood-2010-06-290650","DOI":"10.1182\/blood-2010-06-290650"},{"key":"10.32074\/1591-951X-161_ref65","doi-asserted-by":"crossref","unstructured":"Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 2010:34:405-17. https:\/\/doi.org\/10.1097\/PAS.0b013e3181cf8622","DOI":"10.1097\/PAS.0b013e3181cf8622"},{"key":"10.32074\/1591-951X-161_ref66","doi-asserted-by":"crossref","unstructured":"Natkunam Y, Goodlad JR, Chadburn A, et al. EBV-Positive B-Cell proliferations of varied malignant potential: 2015 SH\/EAHP workshop report-part 1. Am J Clin Pathol 2017:147:129-52. https:\/\/doi.org\/10.1093\/ajcp\/aqw214","DOI":"10.1093\/ajcp\/aqw214"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:25:04Z","timestamp":1730813104000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.pathologica.it\/article\/view\/161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-161","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"article-number":"10"}}